Nevertheless, patients with undifferentiated pleomorphic sarcoma (UPS, GCT cells) showed the highest overall response from treatment with monoclonal antibodies against PD-L1 (33). This evidence concerns the gene CD274 and undifferentiated pleomorphic sarcoma.